Effect of HLA matching on graft survival in live donor kidney transplantations.
Velidedeoğlu
E
E
Turkish Transplantation and Burn Foundation Hospital, Ankara.
Bilgin
N
N
Haberal
M
M
D005190:Family; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000628:therapy; D006085:Graft Survival / Q000276:immunology*; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D010956:Plasmapheresis; D012189:Retrospective Studies; D013997:Time Factors; D014019:Tissue Donors
D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D008775:Methylprednisolone